We thank Wang and Ge for their comments [1] and interest in our multicentre Quality Matters audit [2]. Their letter usefully extends the discussion from the description of low-density lipoprotein cholesterol (LDL-C) management gaps after acute myocardial infarction (AMI) to the more difficult question of how such gaps should be closed.
